[Utility and problems of FRAX in clinical use].
FRAX is developed based on the use of clinical risk factor with or without bone mineral density. It would be expected in diagnosis of osteoporosis that FRAX(R) would be used in a group examination, in medical institution which does not have DEXA, and at home. However, results of FRAX are expressed as percentage indication which is not familiar to Japanese. We did questionnaire survey to the osteoporosis patient about the results of FRAX. As a result, fracture risk is thought of seriously by the initial diagnosis patient, the younger patient, and the patient with interest in osteoporosis. It is necessary to explain fracture risk of FRAX on the basis of patient background in clinical use.
Nakatoh
Shinichi
S
Department of Orthopedic Surgery, Asahi General Hospital, Japan.
D015519:Bone Density; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008403:Mass Screening / Q000379:methods; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D010353:Patient Education as Topic; D012306:Risk; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014944:World Health Organization